Cancer News and Research

Latest Cancer News and Research

Postnova AF2000 system to assist UCL in developing novel nanoscale vehicles for drug delivery

Postnova Analytics reports on the recent investment by the Department of Chemistry at University College London in an AF2000 Field Flow Fractionation System to assist them in their development of novel nanoscale vehicles for drug delivery.

6 Dec 2016

Experimental T-cell therapy shows promise in preventing AML relapse

Fred Hutchinson Cancer Research Center announced promising results from an early trial in which patients with high-risk acute myeloid leukemia received genetically engineered immune cells.

6 Dec 2016

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.

6 Dec 2016

Scientists discover ribosomal protein-based cancer signature

A research team at the University of Basel's Biozentrum has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature.

6 Dec 2016

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

Women treated with a common chemotherapy drug combination have more young eggs in their ovaries afterwards, research has found.

6 Dec 2016

UMass researchers develop new class of photodynamic molecules for treating deep-tissue tumors

UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors.

5 Dec 2016

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

A promising new combination therapy for a particularly aggressive form of breast cancer has been identified by Weizmann Institute scientists, as was recently reported in Cancer Research.

5 Dec 2016

Simple, coordinated approach can improve chances of survival for high-risk AML patients

New research shows that quickly identifying patients with high-risk acute myeloid leukemia (AML), and speeding the process to find them a stem cell donor and performing the transplant earlier, can significantly improve their chances of surviving for at least two years after diagnosis without a relapse.

5 Dec 2016

New study to explore link between sleep and chronic pain

Washington State University will lead a study to understand the relationship between sleep and chronic pain, part of a nationwide effort to address the rising abuse of opioid pain relievers and expand the arsenal of non-drug treatment options.

5 Dec 2016

MUSC researchers harness cutting-edge technology to uncover new role for pericytes during stroke

Pericytes are the primary locus of matrix-mellaproteinase-9-dependent (MMP-9) capillary damage and blood leakage during ischemia, according to preclinical findings reported by Medical University of South Carolina investigators in an article published online on November 14, 2016 by The Journal of Neuroscience.

5 Dec 2016

Researcher developing smartphone-based technology to help people quit smoking

What if a smartphone app could help you avoid relapsing back to smoking even before you knew you were at risk? A researcher from the Oklahoma Tobacco Research Center at the Stephenson Cancer Center is developing smartphone-based technology to help people receive real-time tobacco cessation treatment when they are most at risk.

5 Dec 2016

$UCL invest in Postnova Analytics fractionation system to develop nanoscale drug delivery vehicles$

UCL invest in Postnova Analytics fractionation system to develop nanoscale drug delivery vehicles

Postnova Analytics reports on the recent investment by the Department of Chemistry at University College London (UCL) in an AF2000 Field Flow Fractionation System to assist them in their development of novel nanoscale vehicles for drug delivery.

From Postnova Analytics 5 Dec 2016

New report estimates global burden of cancer cases and deaths in 2015

In 2015, there were an estimated 17.5 million cancer cases around the globe and 8.7 million deaths, according to a new report from the Global Burden of Disease Cancer Collaboration published online by JAMA Oncology.

5 Dec 2016

$Combination treatment produces better outcomes in erythropoietin-refractory MDS patients, study shows$

Combination treatment produces better outcomes in erythropoietin-refractory MDS patients, study shows

Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different types of blood cells, including red blood cells leading to the development of anemia.

4 Dec 2016

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).

4 Dec 2016

Handful of nut consumption each day linked to reduced risk for wide range of diseases

A large analysis of current research shows that people who eat at least 20g of nuts a day have a lower risk of heart disease, cancer and other diseases.

4 Dec 2016

Study explores fitness training approach during breast cancer treatment in multi-sport athlete

Professional athletes undergoing treatment for cancer often are in the headlines.

2 Dec 2016

ACS approves $1.7 million funding for new research grants to Yale University

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University.

2 Dec 2016

Genetic differences between brain cancer cells and normal tissues could offer clues to tumor behavior

Two recently discovered genetic differences between brain cancer cells and normal tissue cells -- an altered gene and a snippet of noncoding genetic material -- could offer clues to tumor behavior and potential new targets for therapy, Johns Hopkins scientists report.

2 Dec 2016

New FDA-approved drug helps patients fight against late-stage lung cancer

A new drug has been approved by the FDA in the fight against lung cancer. Tecentriq is being used by patients like Cornelius Bresnan, who had late-stage cancer.

2 Dec 2016

Cancer News and Research

Latest Cancer News and Research

Postnova AF2000 system to assist UCL in developing novel nanoscale vehicles for drug delivery

Experimental T-cell therapy shows promise in preventing AML relapse

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

Scientists discover ribosomal protein-based cancer signature

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

UMass researchers develop new class of photodynamic molecules for treating deep-tissue tumors

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Simple, coordinated approach can improve chances of survival for high-risk AML patients

New study to explore link between sleep and chronic pain

MUSC researchers harness cutting-edge technology to uncover new role for pericytes during stroke

Researcher developing smartphone-based technology to help people quit smoking

UCL invest in Postnova Analytics fractionation system to develop nanoscale drug delivery vehicles

New report estimates global burden of cancer cases and deaths in 2015

Combination treatment produces better outcomes in erythropoietin-refractory MDS patients, study shows

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Handful of nut consumption each day linked to reduced risk for wide range of diseases

Study explores fitness training approach during breast cancer treatment in multi-sport athlete

ACS approves $1.7 million funding for new research grants to Yale University

Genetic differences between brain cancer cells and normal tissues could offer clues to tumor behavior

New FDA-approved drug helps patients fight against late-stage lung cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in